| Priyadarshani Sharma, MD | |
|
489 State St, Bangor, ME 04401-6616 | |
| (207) 973-6676 | |
| (207) 973-6196 |
| Full Name | Priyadarshani Sharma |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 11 Years |
| Location | 489 State St, Bangor, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790209393 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD23387 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Eastern Maine Medical Center | Bangor, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Maine Medical Center | 2062315161 | 577 |
News Archive
Sunridge International, announced today that China's State Food and Drug Administration, (SFDA), had approved the firm's Pneumatic Trabeculoplasty (PNT) treatment in China.
Researchers have identified a combination of biological markers in patients with dengue that could predict whether they go on to develop moderate to severe disease, according to a study published today in eLife.
Cell Therapeutics, Inc. today announced the final clinical trial design of a randomized pivotal trial of pixantrone for the treatment of diffuse large B-cell lymphoma following discussions with the U.S. Food and Drug Administration's Division of Hematologic Products.
Sun exposure is usually discouraged due to harmful rays causing skin cancer and premature aging but for the 7.5 million Americans suffering from psoriasis, the sun is a natural medication.
Inviragen, Inc. today announced the initiation of the second stage of an ongoing Phase 2, randomized, double-blind, placebo-controlled study of DENVax, the Company's investigational dengue vaccine.
› Verified 1 days ago
| Entity Name | Eastern Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790789147 PECOS PAC ID: 2062315161 Enrollment ID: O20040128000088 |
News Archive
Sunridge International, announced today that China's State Food and Drug Administration, (SFDA), had approved the firm's Pneumatic Trabeculoplasty (PNT) treatment in China.
Researchers have identified a combination of biological markers in patients with dengue that could predict whether they go on to develop moderate to severe disease, according to a study published today in eLife.
Cell Therapeutics, Inc. today announced the final clinical trial design of a randomized pivotal trial of pixantrone for the treatment of diffuse large B-cell lymphoma following discussions with the U.S. Food and Drug Administration's Division of Hematologic Products.
Sun exposure is usually discouraged due to harmful rays causing skin cancer and premature aging but for the 7.5 million Americans suffering from psoriasis, the sun is a natural medication.
Inviragen, Inc. today announced the initiation of the second stage of an ongoing Phase 2, randomized, double-blind, placebo-controlled study of DENVax, the Company's investigational dengue vaccine.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Priyadarshani Sharma, MD 43 Whiting Hill Rd, Brewer, ME 04412-1005 Ph: () - | Priyadarshani Sharma, MD 489 State St, Bangor, ME 04401-6616 Ph: (207) 973-6676 |
News Archive
Sunridge International, announced today that China's State Food and Drug Administration, (SFDA), had approved the firm's Pneumatic Trabeculoplasty (PNT) treatment in China.
Researchers have identified a combination of biological markers in patients with dengue that could predict whether they go on to develop moderate to severe disease, according to a study published today in eLife.
Cell Therapeutics, Inc. today announced the final clinical trial design of a randomized pivotal trial of pixantrone for the treatment of diffuse large B-cell lymphoma following discussions with the U.S. Food and Drug Administration's Division of Hematologic Products.
Sun exposure is usually discouraged due to harmful rays causing skin cancer and premature aging but for the 7.5 million Americans suffering from psoriasis, the sun is a natural medication.
Inviragen, Inc. today announced the initiation of the second stage of an ongoing Phase 2, randomized, double-blind, placebo-controlled study of DENVax, the Company's investigational dengue vaccine.
› Verified 1 days ago
Dr. Leonard C Moneke, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-7000 Fax: 207-973-5042 | |
Dr. James M Mccarthy, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-7000 Fax: 207-973-5042 | |
Dr. Alexandra Craig, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 992 Union St, Bangor, ME 04401 Phone: 207-945-5247 | |
Dr. Savitha Rajan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-7000 Fax: 207-973-5042 | |
Pradeep S Paul, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 360 Broadway, Bangor, ME 04401 Phone: 207-907-3215 Fax: 207-907-1795 | |
Toyiba Hussain Syed, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-6252 Fax: 207-973-5042 | |
Keith Amit Singh, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-6605 Fax: 207-973-4441 |